Comparison of Contrast-Enhanced MRI with Iodine-123 BMIPP for Detection of Myocardial Damage in Hypertrophic Cardiomyopathy
Yasuo Amano1,
Shinichiro Kumita1,
Morimasa Takayama2 and
Tatuso Kumazaki1
1 Department of Radiology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku,
Tokyo 113-8603, Japan. 2 Department of First Internal Medicine, Nippon Medical School, Tokyo,
Japan.
Fig. 1A24-year-old woman with hypertrophic cardiomyopathy.
Contrast-enhanced MR image (A) and SPECT image (B) reveal that
hypertrophied interventricular septal and anterior walls show delayed
hyperenhancement (arrows, A) and decreased uptake of
iodine-123 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid of
myocardium.
Fig. 1B24-year-old woman with hypertrophic cardiomyopathy.
Contrast-enhanced MR image (A) and SPECT image (B) reveal that
hypertrophied interventricular septal and anterior walls show delayed
hyperenhancement (arrows, A) and decreased uptake of
iodine-123 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid of
myocardium.
Fig. 2B68-year-old woman with hypertrophic cardiomyopathy. However,
iodine-123 15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid SPECT image
shows normal uptake.
Fig. 2C68-year-old woman with hypertrophic cardiomyopathy. Cine MR
images obtained at end-diastole (C) and end-systole (D) show
hypertrophied interventricular septum.
Fig. 2D68-year-old woman with hypertrophic cardiomyopathy. Cine MR
images obtained at end-diastole (C) and end-systole (D) show
hypertrophied interventricular septum.
Fig. 3B79-year-old woman with hypertrophic cardiomyopathy. However,
reduced uptake on SPECT image of iodine-123
15-(p-iodophenyl)-3-(R,S)-methylpentadecanoic acid, which suggests preceding
impairment of fatty acid metabolism, is investigated in interventricular
septum.
Fig. 4Graph shows correlation between number of segments with
delayed hyperenhancement and left ventricular ejection fraction. There was
inverse correlation between number of hyperenhancing segments and left
ventricular ejection fraction in 21 of 23 hypertrophic cardiomyopathy patients
with high value of ejection fraction (p = 0.012; r =
0.53; Y = 1.47 x X + 81.98). Vertical line = left
ventricular ejection fraction, diagonal line = number of hyperenhancing
segments.